UAB-UCSD O'Brien Center for Acute Kidney Injury Research
UAB-UCSD 奥布莱恩急性肾损伤研究中心
基本信息
- 批准号:10746567
- 负责人:
- 金额:$ 88.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcute Renal Failure with Renal Papillary NecrosisAddressAlabamaBiomedical ResearchCaliforniaCenter Core GrantsChronic Kidney FailureClinicalClinical ResearchCollaborationsCollectionCommunitiesCore FacilityDataDevelopmentEcosystemElectronic Health RecordEnsureEnvironmentExtramural ActivitiesFosteringFunctional disorderFundingHealthHealthcareHospitalizationHospitalsImaginationInfrastructureInstitutionInvestigationKidneyKidney DiseasesLearningLength of StayMachine LearningMethodsMissionMorbidity - disease rateNational Institute of Diabetes and Digestive and Kidney DiseasesPaperPatientsPreventionPublicationsQuality ControlReproducibilityResearchResearch Peer ReviewResearch PersonnelResource DevelopmentResource SharingResourcesRodent ModelServicesTechnologyTestingTraining ProgramsTranslational ResearchUniversitiesdigitalexperienceimprovedin vivo imaginginnovationmembermetabolomicsmortalitypre-clinicalpre-clinical researchquality assurancesummer studenttool
项目摘要
Overall - Project Summary
Kidney diseases in general and acute kidney injury (AKI) in particular impose substantial morbidity and
mortality that remain unabated despite concerted efforts in recent decades to reduce both. The overall mission
of the UAB-UCSD O’Brien Center for AKI Research is to improve the health of patients by fostering research
specifically targeted to the prevention and treatment of AKI and its complications. To achieve this mission,
our two institution-based Center crosses institutional boundaries and research fields, harnessing the
momentum and ingenuity of ongoing pre-clinical and clinical research in each of our institutions and nationally.
In this application to become a National Resource Center (NRC) in the O’Brien Kidney Consortium, our theme-
based Center proposes to share and combine resources, methods, innovations, and other expertise with the
other NRCs, under the guidance of the Steering Committee, National Coordinating Center, and NIDDK, to
attract new scientific expertise into the field and coordinate and prioritize resource development and
innovative services that are most essential to the Consortium. The following aims are proposed: (1) Integrate
our O’Brien Center into the Consortium to accelerate the pace of AKI-related research through the support of
shared Core facilities and expertise while ensuring quality assurance/quality control, rigor, and reproducibility
for the Core services; (2) Foster meaningful interactions among investigators in the Consortium; (3) Through
the NCC and the Consortium, share the Center’s intellectual resources and infrastructure to expand the
diversity of investigators in AKI-related research, with an emphasis on early-stage investigators; (4) Utilize
our Resource Development Core to respond to the evolving needs of investigators through promotion of
innovative lines of investigation in AKI-related research; (5) Develop tomorrow’s thought leaders through our
Summer Student Training Program; and (6) Leverage our substantial institutional commitments to propel the
development of AKI-related research within the Consortium. The proposed Biomedical Research Cores (a
Clinical Core and a Pre-clinical Core) and Resource Development Core will integrate existing intellectual and
technological resources to provide the Consortium a set of services/resources for innovative investigation in
AKI-related research. Our Clinical Core will uniquely build upon established networks and infrastructure in
clinical AKI research, including a large biospecimen collection, and through the use of a collaborative digital
workspace, enhance these resources and make them readily available to the Consortium. Simultaneously,
our Pre-Clinical Core will uniquely provide the breadth of expertise, experimental tools, and resources to help
investigators overcome barriers to the utilization of relevant rodent models and advance understanding of the
pathophysiology of AKI. To advance both realms, our Resource Development Core will provide a dynamic
platform to develop, test, and refine innovations, including new analytical approaches in metabolomics and
functional in vivo imaging and tools for federated machine learning using big electronic health record data.
总体 - 项目摘要
肾脏疾病一般和急性肾脏损伤(AKI)尤其引发了大量的发病率和
近几十年来,死亡率仍然是尚未减弱的一致努力,以减少两者。整体任务
UAB-UCSD O'Brien AKI研究中心是通过促进研究来改善患者的健康状况
专门针对预防和治疗AKI及其并发症。为了实现这一任务,
我们的两个基于机构的中心跨越机构边界和研究领域,利用
我们每个机构和全国范围内正在进行的临床前和临床研究的动力和创造力。
在此申请中成为奥布莱恩肾脏财团的国家资源中心(NRC),我们的主题 -
基于共享和结合资源,方法,创新和其他专业知识的中心建议
在指导委员会,国家协调中心和NIDDK的指导下,其他NRCS
吸引新的科学专业知识进入该领域,协调和优先考虑资源开发和优先级
对财团最重要的创新服务。提出了以下目的:(1)整合
我们的奥布莱恩中心进入财团,通过支持
共享核心设施和专业知识,同时确保质量保证/质量控制,严格和可重复性
用于核心服务; (2)促进财团研究人员之间有意义的相互作用; (3)通过
NCC和财团,共享该中心的智力资源和基础设施,以扩展
研究人员在与AKI相关的研究中的多样性,重点是早期研究人员; (4)利用
我们的资源开发核心通过促进调查人员的需求做出响应
与AKI相关研究的创新投资线; (5)通过我们的明天的思想领袖
夏季学生培训计划; (6)利用我们实质性的机构承诺来推动
在财团内开发与AKI相关的研究。提出的生物医学研究核心(a
临床核心以及临床前的核心)和资源开发核心将整合现有的知识分子和
为财团提供一组服务/资源以创新投资的技术资源
与AKI相关的研究。我们的临床核心将在既定的网络和基础设施中唯一建立
临床AKI研究,包括大型的生物循环收集,并通过使用协作数字
工作空间,增强这些资源,并使财团容易获得。同时地,
我们的临床前核心将唯一提供专业知识,实验工具和资源的广度,以帮助
研究人员克服了利用相关啮齿动物模型的障碍,并提高了对
AKI的病理生理学。为了促进这两个领域,我们的资源开发核心将提供动态
开发,测试和完善创新的平台,包括代谢组学和
使用大型电子健康记录数据,用于联合机器学习的体内成像和工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANUPAM AGARWAL其他文献
ANUPAM AGARWAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANUPAM AGARWAL', 18)}}的其他基金
Mononuclear phagocytes in the pathogenesis of acute kidney injury
单核吞噬细胞在急性肾损伤发病机制中的作用
- 批准号:
9888371 - 财政年份:2019
- 资助金额:
$ 88.37万 - 项目类别:
Mononuclear phagocytes in the pathogenesis of acute kidney injury
单核吞噬细胞在急性肾损伤发病机制中的作用
- 批准号:
10083733 - 财政年份:2019
- 资助金额:
$ 88.37万 - 项目类别:
Mononuclear phagocytes in the pathogenesis of acute kidney injury
单核吞噬细胞在急性肾损伤发病机制中的作用
- 批准号:
10536615 - 财政年份:2019
- 资助金额:
$ 88.37万 - 项目类别:
Mononuclear phagocytes in the pathogenesis of acute kidney injury
单核吞噬细胞在急性肾损伤发病机制中的作用
- 批准号:
10320001 - 财政年份:2019
- 资助金额:
$ 88.37万 - 项目类别:
Mononuclear phagocytes in the pathogenesis of acute kidney injury
单核吞噬细胞在急性肾损伤发病机制中的作用
- 批准号:
9763077 - 财政年份:2019
- 资助金额:
$ 88.37万 - 项目类别:
Project 3: Intercepting Renal Damage following Skin Exposure to Arsenicals
项目 3:阻止皮肤接触砷剂后的肾损伤
- 批准号:
10249115 - 财政年份:2018
- 资助金额:
$ 88.37万 - 项目类别:
Project 3: Intercepting Renal Damage following Skin Exposure to Arsenicals
项目 3:阻止皮肤接触砷剂后的肾损伤
- 批准号:
9564422 - 财政年份:2018
- 资助金额:
$ 88.37万 - 项目类别:
Lymphangiogenesis in the pathogenesis of Acute Kidney Injury
急性肾损伤发病机制中的淋巴管生成
- 批准号:
10046290 - 财政年份:2017
- 资助金额:
$ 88.37万 - 项目类别:
Lymphangiogenesis in the pathogenesis of acute kidney injury
急性肾损伤发病机制中的淋巴管生成
- 批准号:
10482538 - 财政年份:2017
- 资助金额:
$ 88.37万 - 项目类别:
相似海外基金
Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
- 批准号:
10638267 - 财政年份:2023
- 资助金额:
$ 88.37万 - 项目类别:
Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
- 批准号:
10740665 - 财政年份:2023
- 资助金额:
$ 88.37万 - 项目类别:
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
肝硬化患者肾脏健康的新型生物标志物对急性肾损伤发生风险和可逆性的分层
- 批准号:
10675684 - 财政年份:2022
- 资助金额:
$ 88.37万 - 项目类别:
Mount Sinai Health System Kidney Precision Medicine Project
西奈山卫生系统肾脏精准医学项目
- 批准号:
10703420 - 财政年份:2022
- 资助金额:
$ 88.37万 - 项目类别: